Advice on the use of AmnioSense (non-invasive diagnostic pad/liner) for unexplained vaginal wetness in pregnancy to aid local decision making
A review of the impact our evidence-based guidance has on improvements in lung cancer.
The section of the NICEimpact lung cancer report looking at how lung cancer can be prevented.
The section of the NICE impact lung cancer report looking at how lung cancer is detected.
The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care.
The section of the NICE impact lung cancer report looking at how the disease is treated.
The section of the NICE impact lung cancer report looking at how patients are treated during their care.
Professor Michael Peake September 2019 In England the average 5-year survival rate for people diagnosed with lung cancer between 1991 and 1993 was 5%
Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart
Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart
Biographies and interests register for the indicator advisory committee
Why seek advice? Our evaluation programmes require certain types of evidence about the technology being appraised. Our advice ensures that your...
Evidence-based recommendations on fluocinolone acetonide intravitreal implant (Iluvien) for chronic diabetic macular oedema that has inadequately responded to
Preventing unintentional injuries among under-15s in the home, on the road and in outdoor play and leisure environments.
Everything NICE has said on assessing and managing familial breast cancer and related risks in people with a family history in an interactive flowchart
Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making
Everything NICE has said on preventing, detecting and managing acute kidney injury in an interactive flowchart
This guideline covers how to help people return to work after long-term sickness absence, reduce recurring sickness absence, and help prevent people moving from short-term to long-term sickness absence.
This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.
This guideline covers care for people with a family history of breast, ovarian or another related (prostate or pancreatic) cancer. It aims to improve the long-term health of these families by describing strategies to reduce the risk of and promote early detection of breast cancer (including genetic testing and mammography). It also includes advice on treatments (tamoxifen, raloxifene) and surgery (mastectomy).
Evidence-based recommendations on neratinib (Nerlynx) for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer
Everything NICE has said on thyroid disease in children, young people and adults in an interactive flowchart
Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults
Everything NICE has said on managing long-term sickness absence and capability to work in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart
Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart
Recommendation ID NG19/12 Question When is it safe to stop contact casting in the treatment of acute Charcot arthropathy? Any explanatory
Recommendation ID NG19/11 Question Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy? Any
Recommendation ID NG19/10 Question What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot
Recommendation ID NG19/9 Question What is the clinical effectiveness of negative pressure wound therapy in the treatment of diabetic foot
Recommendation ID NG142/2 Question Which of the electronic information-sharing systems perform best for the care of people approaching the
Recommendation ID NG142/1 Question Does early review of service provision and referral to additional specialist palliative care services
Recommendation ID NG142/3 Question What are the benefits of planned, regular community-based reviews compared with as-required review of
Recommendation ID NG142/4 Question What is the optimal way of discharging people approaching the end of their life from hospitals back to
Recommendation ID IPG663/1 Question Evidence on the safety and efficacy of midcarpal hemiarthroplasty for wrist arthritis is inadequate
Recommendation ID NG19/8 Question How often should people with diabetic foot problems (foot ulcers, soft tissue infections, osteomyelitis
How to submit a new medical technology to NICE for guidance